Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen's secondary activities so that it might work on more aggressive breast cancer.
http://www.eurekalert.org/pub_releases/2013-04/uorm-rin042313.php
http://www.eurekalert.org/pub_releases/2013-04/uorm-rin042313.php
No comments:
Post a Comment